{
    "name": "iopromide",
    "comment": "Rx",
    "other_names": [
        "Ultravist"
    ],
    "classes": [
        "Iodinated Contrast Media"
    ],
    "source": "https://reference.medscape.com/drug/ultravist-iopromide-343771",
    "pregnancy": {
        "common": [
            "There are no data on use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Drug crosses placenta and reaches fetal tissues in small amounts"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies, intravenous administration of iopromide to pregnant rats and rabbits during organogenesis at doses up to 0.35 and 0.7 times, respectively, maximum recommended human dose based on body surface area resulted in no relevant adverse developmental effects"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on the presence of drug in human milk, effects on the breastfed infant, or the effects on milk production. Iodinated contrast agents are poorly excreted into human milk and are poorly absorbed by the gastrointestinal tract of a breastfed infant",
            "The developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for therapy and any potential adverse effects on breastfed infant from treatment or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "May be fatal if given intrathecally",
                "Serious adverse events reported from inadvertent intrathecal administration including paralysis, coma, acute renal failure, seizures, cardiac arrest, rhabdomyolysis, convulsions, cerebral hemorrhage, hyperthermia, and brain edema"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Intrathecal administration",
                "Preparatory dehydration (prolonged fasting, bowel prep) before injection in pediatric patients is contraindicated due to risk of acute renal failure"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Severe cutaneous adverse reactions (SCAR) may develop from 1 hr to several weeks after intravascular contrast agent administration; reactions include Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), acute generalized exanthematous pustulosis (AGEP) and drug reaction with eosinophilia and systemic symptoms (DRESS); reaction severity may increase and time to onset may decrease with repeat administration of contrast agent; prophylactic medications may not prevent or mitigate severe cutaneous adverse reactions; avoid administering therapy to patients with history of a severe cutaneous adverse reaction to therapy",
                "Contrast-induced acute kidney injury; adequately hydrate before and after procedure",
                "Monitor closely postprocedure with if patient has preexisting cardiovascular disease",
                "Monitor electrocardiogram and vital signs throughout procedure",
                "If possible, avoid angiography with homocystinuria (increased risk for thrombosis/embolism)",
                "Delayed adverse reactions may occur; monitor patient for 30-60 min after injection",
                "Consider monitoring for thyroid storm in patients with hyperthyroidism,",
                "Caution in patients with seizures, thromboembolic diseases including IM and stroke, chronic alcoholism, heart failure, diabetes mellitus, hepatorenal insufficiency, multiple myeloma, pheochromocytoma, renal disease, sickle cell disease",
                "Sickle cell disease: Contrast agents may promote sickling following administration in homozygous genotypes"
            ],
            "specific": [
                {
                    "type": "Thyroid dysfunction in pediatric patients",
                    "description": [
                        "Thyroid dysfunction characterized by hypothyroidism or transient thyroid suppression reported after both single exposure and multiple exposures to iodinated contrast media in pediatric patients 0 to 3 years of age",
                        "Younger age, very low birth weight, prematurity, underlying medical conditions affecting thyroid function, admission to neonatal or pediatric intensive care units, and congenital cardiac conditions are associated with increased risk of hypothyroidism after ICM exposure",
                        "Pediatric patients with congenital cardiac conditions may be at greatest risk given that they often require high doses of contrast during invasive cardiac procedures",
                        "An underactive thyroid during early life may be harmful for cognitive and neurological development and may require thyroid hormone replacement therapy",
                        "After exposure to iodinated contrast media, individualize thyroid function monitoring in pediatric patients 0-3 years of age based on underlying risk factors, especially in term and preterm neonates",
                        "Pediatric patients 0-3 years of age warrant closer monitoring because an underactive thyroid during early life may be harmful to motor, hearing, and cognitive development and may require transient T4 replacement therapy"
                    ]
                },
                {
                    "type": "Drug-laboratory Test Interactions",
                    "description": [
                        "Thyroid Function Tests: Protein-bound iodine and radioactive iodine uptake studies, may not accurately reflect thyroid function for at least 16 days following administration",
                        "Laboratory Assay of Coagulation Parameters, Fibrinolysis and Complement System: The effect of iopromide on coagulation factors in in-vitro assays increased with the administered dose."
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Epistaxis",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Migraine",
            "percent": null
        },
        {
            "name": "Joint disorder",
            "percent": null
        },
        {
            "name": "effusion",
            "percent": null
        },
        {
            "name": "Muscle cramps",
            "percent": null
        },
        {
            "name": "Mucous membrane disorder",
            "percent": null
        },
        {
            "name": "mucosal swelling",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Hypoxia",
            "percent": null
        },
        {
            "name": "Fixed eruptions",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Diabetes insipidus",
            "percent": null
        },
        {
            "name": "Cerebral edema",
            "percent": null
        }
    ]
}